493OTepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data. (25th November 2018) - Sakai, H; Felip, E; Cortot, A B; Veillon, R; Griesinger, F; Patel, J; Horn, L; Mazieres, J; De Castro Carpeno, J; Morise, M; Sakamoto, T; Bruns, R; et al.